Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUCMSC Secretome in Moderate Dementia
NCT06632470Phase 1Not yet recruiting
- Sponsor
- Baermed
- Start
- Oct 2024
- Primary completion
- May 2025
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 1, randomised trial of human umbilical cord mesenchymal stem cell secretome in Dementia (2 arms), sponsored by Baermed. Primary endpoints: Blood parameters (hemoglobin, hematocrit, leukocyte, thrombocyte, HbA1c, kidney function, liver function), Mini Mental State Examination and 3 more. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cell secretome
03
Conditions
Dementia
Beyond the preview
Go deeper on NCT06632470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06632470.